209 related articles for article (PubMed ID: 29314745)
21.
Willsey GG; Eckstrom K; LaBauve AE; Hinkel LA; Schutz K; Meagher RJ; LiPuma JJ; Wargo MJ
J Bacteriol; 2019 Aug; 201(15):. PubMed ID: 31109991
[No Abstract] [Full Text] [Related]
22. Detecting Stenotrophomonas maltophilia does not reduce survival of patients with cystic fibrosis.
Goss CH; Otto K; Aitken ML; Rubenfeld GD
Am J Respir Crit Care Med; 2002 Aug; 166(3):356-61. PubMed ID: 12153970
[TBL] [Abstract][Full Text] [Related]
23. Air pollution exposure is associated with MRSA acquisition in young U.S. children with cystic fibrosis.
Psoter KJ; De Roos AJ; Wakefield J; Mayer JD; Rosenfeld M
BMC Pulm Med; 2017 Jul; 17(1):106. PubMed ID: 28750627
[TBL] [Abstract][Full Text] [Related]
24. Role of Stenotrophomonas maltophilia isolation in patients with non-CF bronchiectasis.
Marra R; Sgalla G; Richeldi L; Conte EG; Hill AT
QJM; 2020 Oct; 113(10):726-730. PubMed ID: 32275749
[TBL] [Abstract][Full Text] [Related]
25. Denitrification by cystic fibrosis pathogens - Stenotrophomonas maltophilia is dormant in sputum.
Kolpen M; Kragh KN; Bjarnsholt T; Line L; Hansen CR; Dalbøge CS; Hansen N; Kühl M; Høiby N; Jensen PØ
Int J Med Microbiol; 2015 Jan; 305(1):1-10. PubMed ID: 25441256
[TBL] [Abstract][Full Text] [Related]
26. Association between Stenotrophomonas maltophilia and lung function in cystic fibrosis.
Goss CH; Mayer-Hamblett N; Aitken ML; Rubenfeld GD; Ramsey BW
Thorax; 2004 Nov; 59(11):955-9. PubMed ID: 15516471
[TBL] [Abstract][Full Text] [Related]
27. Significance of positive Stenotrophomonas maltophilia culture in acute respiratory tract infection.
Pathmanathan A; Waterer GW
Eur Respir J; 2005 May; 25(5):911-4. PubMed ID: 15863651
[TBL] [Abstract][Full Text] [Related]
28. Pathophysiology and management of pulmonary infections in cystic fibrosis.
Gibson RL; Burns JL; Ramsey BW
Am J Respir Crit Care Med; 2003 Oct; 168(8):918-51. PubMed ID: 14555458
[TBL] [Abstract][Full Text] [Related]
29. Stenotrophomonas maltophilia: to be or not to be a cystic fibrosis pathogen.
Hansen CR
Curr Opin Pulm Med; 2012 Nov; 18(6):628-31. PubMed ID: 22990659
[TBL] [Abstract][Full Text] [Related]
30. Adaptation of Stenotrophomonas maltophilia in cystic fibrosis: molecular diversity, mutation frequency and antibiotic resistance.
Vidigal PG; Dittmer S; Steinmann E; Buer J; Rath PM; Steinmann J
Int J Med Microbiol; 2014 Jul; 304(5-6):613-9. PubMed ID: 24836944
[TBL] [Abstract][Full Text] [Related]
31. Cystic Fibrosis-Associated Stenotrophomonas maltophilia Strain-Specific Adaptations and Responses to pH.
Gallagher T; Phan J; Oliver A; Chase AB; England WE; Wandro S; Hendrickson C; Riedel SF; Whiteson K
J Bacteriol; 2019 Apr; 201(7):. PubMed ID: 30642989
[TBL] [Abstract][Full Text] [Related]
32. Antibiotic treatment of multidrug-resistant organisms in cystic fibrosis.
Conway SP; Brownlee KG; Denton M; Peckham DG
Am J Respir Med; 2003; 2(4):321-32. PubMed ID: 14719998
[TBL] [Abstract][Full Text] [Related]
33. Pseudomonas aeruginosa Promotes Persistence of Stenotrophomonas maltophilia via Increased Adherence to Depolarized Respiratory Epithelium.
McDaniel MS; Lindgren NR; Billiot CE; Valladares KN; Sumpter NA; Swords WE
Microbiol Spectr; 2023 Feb; 11(1):e0384622. PubMed ID: 36472421
[TBL] [Abstract][Full Text] [Related]
34. Antimicrobial susceptibility profile of molecular typed cystic fibrosis Stenotrophomonas maltophilia isolates and differences with noncystic fibrosis isolates.
Cantón R; Valdezate S; Vindel A; Sánchez Del Saz B; Maíz L; Baquero F
Pediatr Pulmonol; 2003 Feb; 35(2):99-107. PubMed ID: 12526070
[TBL] [Abstract][Full Text] [Related]
35. Use of random amplified polymorphic DNA PCR to examine epidemiology of Stenotrophomonas maltophilia and Achromobacter (Alcaligenes) xylosoxidans from patients with cystic fibrosis.
Krzewinski JW; Nguyen CD; Foster JM; Burns JL
J Clin Microbiol; 2001 Oct; 39(10):3597-602. PubMed ID: 11574579
[TBL] [Abstract][Full Text] [Related]
36. Pulmonary exacerbation due to colistin-resistant Stenotrophomonas maltophilia in a Bulgarian cystic fibrosis patient.
Stoyanova GP; Strateva TV; Atanasova ST; Miteva DS; Papochieva VE; Perenovska PI
Folia Med (Plovdiv); 2016; 58(2):136-40. PubMed ID: 27552791
[TBL] [Abstract][Full Text] [Related]
37. Taxonomic position, antibiotic resistance and virulence factor production by Stenotrophomonas isolates from patients with cystic fibrosis and other chronic respiratory infections.
Fluit AC; Bayjanov JR; Aguilar MD; Cantón R; Elborn S; Tunney MM; Scharringa J; Benaissa-Trouw BJ; Ekkelenkamp MB
BMC Microbiol; 2022 May; 22(1):129. PubMed ID: 35549675
[TBL] [Abstract][Full Text] [Related]
38. Adhesion to and biofilm formation on IB3-1 bronchial cells by Stenotrophomonas maltophilia isolates from cystic fibrosis patients.
Pompilio A; Crocetta V; Confalone P; Nicoletti M; Petrucca A; Guarnieri S; Fiscarelli E; Savini V; Piccolomini R; Di Bonaventura G
BMC Microbiol; 2010 Apr; 10():102. PubMed ID: 20374629
[TBL] [Abstract][Full Text] [Related]
39. Risk factors for levofloxacin resistance in Stenotrophomonas maltophilia from respiratory tract in a regional hospital.
Pien CJ; Kuo HY; Chang SW; Chen PR; Yeh HW; Liu CC; Liou ML
J Microbiol Immunol Infect; 2015 Jun; 48(3):291-5. PubMed ID: 24239064
[TBL] [Abstract][Full Text] [Related]
40. [Analysis of clinical characteristics and drug sensitivity tests of lower respiratory tract infection by Xanthomonas maltophilia].
Liu Z; Zhao Z; Xiong J
Zhonghua Jie He He Hu Xi Za Zhi; 1999 Apr; 22(4):211-3. PubMed ID: 11775914
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
